PCPutthiporn Charoenphun

Putthiporn Charoenphun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Putthiporn Charoenphun has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach

    by Sasithorn Amnuaywattakorn, Putthiporn Charoenphun, Touch Ativitavas, Panya Pasawang, Kitiwat Khamwan, Thonnapong Thongpraparn, Benjapa Khiewvan, Ponkittiya Ruangma, Wichana Chamroonrat, Krisanat Chuamsaamarkkee

    First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach - Molecular Imaging and Radionuclide Therapy


  • Single time-point kidney dosimetry in 177Lu-PSMA therapy: A comparison between AI-based and manual segmentation approaches

    by Thitaya Chaiwongsa, Putthiporn Charoenphun, Wichana Chamroonrat, Krisanat Chuamsaamarkkee

    Background: Single time-point (STP) dosimetry has become a practical and efficient approach for personalised radioligand therapy (RLT), with 48-hours post-injection identified as optimal for kidney dose estimation in ¹⁷⁷Lu-PSMA therapy for prostate cancer. However, segmentation accuracy remains a critical factor affecting dosimetry reliability. AI-based segmentation has recently been integrated into commercial software to improve efficiency and reduce variability. Objectives: This study aims to quantify kidney absorbed doses in patients receiving ¹⁷⁷Lu-PSMA therapy using STP dosimetry and to compare the accuracy and consistency of AI-based segmentation versus manual segmentation techniques. Materials and methods: Eight treatment cycles from 5 patients of ¹⁷⁷Lu-PSMA were retrospectively analysed. In this work, whole-body SPECT/CT imaging was performed approximately 48 hours post-injection. Then, kidney dosimetry was calculated using voxel-based STP (Hänscheid method) within MIM SurePlan™ MRT software. Kidney volumes of interest (VOIs) were segmented using three approaches: 1) AI-based automatic segmentation, 2) AI-based with manual refinement, and 3) fully manual segmentation. Mean absorbed doses and VOI volumes were compared across methods. Statistical analyses included ANOVA, Dice Similarity Coefficient (DSC), and Jaccard Similarity Coefficient (JSC). Results: No significant differences in mean kidney absorbed doses were found across segmentation methods (p=0.964), while kidney VOI volumes showed significant variation (p<0.05). AI-based segmentation achieved high concordance with manual delineation (DSC: 0.898±0.019; JSC: 0.816±0.031). Conclusion: AI-based segmentation provides comparable absorbed dose results to manual segmentation, with reduced time and inter-observer variability.


  • Open Access

    Monte Carlo simulation of eye lens dose and shielding effectiveness for radiation workers in nuclear medicine

    by Pakjira Morhrasi, Chayanit Jumpee, Vithit Pungkun, Tanapol Dachiviriyakij, Phiphat Phruksarojanakun, Waraporn Sudchai, Putthiporn Charoenphun, Krisanat Chuamsaamarkkee

    The aim of this work was to estimate the eye lens dose equivalent at a depth of 3 mm and to evaluate the effectiveness of shielding for radiation workers in nuclear medicine using Monte Carlo simulation with the Monte Carlo N-Particle transport code, version 5. Published air kerma rate constants were used to validate the simulation code for commonly used radionuclides in nuclear medicine, including $ ^{18}\mathrm{F} $, $ ^{99m}\mathrm{Tc} $, and $ ^{131}\mathrm{I} $. Eye lens dose rates with commercially available syringe shields and vial shields were simulated using the Monte Carlo N-Particle code with the Posture, Individual, and Medical Application Laboratory phantom. Shielded and unshielded eye lens dose rates based on commercially available source data were simulated for common radionuclides at various distances. The maximum number of procedures was also estimated based on the eye lens dose limit recommended by the International Commission on Radiological Protection publication 118. The simulated dose rates may be used to evaluate radiation safety considerations for workers in nuclear medicine. Appropriate shielding and eye lens monitoring are particularly recommended for positron-emitting $ ^{18}\mathrm{F} $ and high-activity $ ^{131}\mathrm{I} $ procedures.

  • Flexible gamma ray shielding based on natural Rubber/BaSO4 nanocomposites

    by Nattha Plangpleng, Putthiporn Charoenphun, Duangporn Polpanich, Kartpan Sakulkaew, Nichapa Buasuwan, Orasa Onjun, Krisanat Chuamsaamarkkee


  • Open Access

    A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment

    by Kween Saimuang, Khomson Suttisintong, Narongpol Kaewchangwat, Eknarin Thanayupong, Yodsathorn Wongngam, Putthiporn Charoenphun, Rujira Wanotayan, Abdelhamid Elaissari, Suradej Hongeng, Duangporn Polpanich, et al.

    127I-modified mIBG was successfully synthesized and grafted covalently to the surface of carboxylated PEG-GNPs. The particles were not toxic to the normal fibroblast cells while specifically internalized into neuroblastoma cells line via NET.


  • Open Access

    Red Marrow Absorbed Dose Calculation in Thyroid Cancer Patient Using a Simplified Excel Spreadsheet

    by Rangsee Songprakhon, Krisana Roysri, Putthiporn Charoenphun, Krisanat Chuamsaamarkkee

    Absorbed dose to red marrow (Drm) can be calculated using blood dosimetry. However, this method is laborious and invasive. Therefore, image-based dosimetry is the method of choice. Nonetheless, the commercial software is expensive. The goal of this work was to develop a simplified excel spreadsheet for image-based radioiodine red marrow dosimetry. The serial whole-body images (acquired at 2nd, 6th, 24th, 48th, and 72th hours) of 29 patients from the routine pretherapeutic dosimetry protocol were retrospectively reanalyzed. The commercial OLINDA/EXM image-based dosimetry software was used to calculate the whole-body time-integrated activity coefficient (TIACWB) and Drm [in terms of absorbed dose coefficient (drm)]. For the simplified excel spreadsheet, the whole-body count was obtained from the vendor-supplied software. Then, the TIACWB was computed by a fitting time-activity curve using an Excel function. S factor was taken from other publications and scaled according to the patient-specific mass. A comparison of the TIACWB and drm from both methods was done using a non-inferiority test using a paired t-test or the Wilcoxon signed-rank test. The TIACWB showed no significant difference between both methods (p=0.243). The calculated Drm from a simplified Excel spreadsheet was assumed to be statistically non-inferior to the commercial OLINDA/EXM image-based dosimetry software with the non-inferiority margin of 0.02 (p<0.05). The dose assessment from a simplified Excel spreadsheet is feasible and relatively low cost compared to the commercial OLINDA/EXM image-based dosimetry software.